| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Kylo-11 | Kylo-11; Kylo11 | Phase 2 Clinical | Shanghai Hejiya Biopharmaceutical Co Ltd, Xiamen Ganbaoli Biopharmaceutical Co Ltd | Atherosclerosis; Cardiovascular Diseases; Hyperlipoproteinemias; Lipid Metabolism Disorders | Details |
